Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Gastrointestinal Stromal Tumors 31Sarcoma 7Osteosarcoma 4Sarcoma, Alveolar Soft Part 3Neoplasm Metastasis 3Leiomyosarcoma 3Histiocytoma, Malignant Fibrous 3Gliosarcoma 3Gastrointestinal Neoplasms 3Carcinoma, Renal Cell 3Sarcoma, Synovial 2Liposarcoma 2Hemangiosarcoma 2Glioma 2Glioblastoma 2Fibrosarcoma 2Chondrosarcoma, Extraskeletal Myxoid 2Chondrosarcoma 2Carcinoma, Non-Small-Cell Lung 2Bone Neoplasms 2Adenoma, Islet Cell 2Thyroid Neoplasms 1Somatostatinoma 1Solitary Fibrous Tumors 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Sarcoma, Clear Cell 1Rhabdomyosarcoma 1Ovarian Neoplasms 1

Interventions

Temozolomide 32Radiotherapy 11Magnetic Resonance Spectroscopy 11Carboplatin 10Bevacizumab 10Irinotecan 9Carmustine 9Filgrastim 8Erlotinib Hydrochloride 8Surgical Procedures, Operative 7sargramostim 5Imatinib Mesylate 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 52,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5temsirolimus 4Vorinostat 4Sirolimus 4Procarbazine 4Peripheral Blood Stem Cell Transplantation 4O(6)-benzylguanine 4aldesleukin 3Thalidomide 3Iodine-125 3Immunohistochemistry 3Gadolinium DTPA 3Cyclophosphamide 3Bortezomib 3Biopsy 3lonafarnib 2imetelstat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oligodendroglioma × Sunitinib × Sarcoma × Clear all
NCT00499473 2016-02-29

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

National Cancer Institute (NCI)

Phase 2 Completed
31 enrolled 6 charts
CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡